Finding and Evaluating Generic Drug Market Entry Opportunities

Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry opportunities Litigation-free generic launch strategies How to leverage 505(b)(2) and branded generics How to learn from litigation This talk is based on my work at […] Source